Yong-Jun Wang Selected Research

muscone

1/2020	Muscone Ameliorates LPS-Induced Depressive-Like Behaviors and Inhibits Neuroinflammation in Prefrontal Cortex of Mice.
1/2020	Muscone suppresses inflammatory responses and neuronal damage in a rat model of cervical spondylotic myelopathy by regulating Drp1-dependent mitochondrial fission.
10/2013	Effects of Qishe Pill, a compound traditional Chinese herbal medicine, on cervical radiculopathy: study protocol for a randomized controlled trial.
6/2010	Muscone protects vertebral end-plate degeneration by antiinflammatory property.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yong-Jun Wang Research Topics

Disease

39	Stroke (Strokes) 07/2022 - 10/2008
22	Ischemic Stroke 06/2022 - 05/2009
12	Pain (Aches) 01/2022 - 01/2010
9	Inflammation (Inflammations) 06/2022 - 02/2009
8	Transient Ischemic Attack 10/2021 - 10/2008
7	Neck Pain (Cervicalgia) 01/2022 - 01/2010
7	Osteoporosis 11/2019 - 06/2010
6	Spinal Cord Injuries (Spinal Cord Injury) 01/2022 - 02/2016
6	Osteoarthritis 07/2019 - 02/2009
6	Neoplasms (Cancer) 04/2019 - 12/2005
5	Hypertension (High Blood Pressure) 07/2022 - 12/2008
5	Atrial Fibrillation 07/2022 - 08/2010
5	Wounds and Injuries (Trauma) 01/2022 - 07/2014
5	Radiculopathy (Radiculopathy, Cervical) 06/2021 - 11/2003
5	Arthritis (Polyarthritis) 02/2019 - 09/2009
5	Intervertebral Disc Degeneration 01/2017 - 02/2007
4	Neuroinflammatory Diseases 01/2022 - 01/2019
4	Carcinogenesis 01/2019 - 04/2008
3	Bone Diseases (Bone Disease) 04/2022 - 01/2011
3	Infarction (Infarctions) 01/2022 - 12/2009
3	Deglutition Disorders (Dysphagia) 01/2022 - 01/2021
3	Body Weight (Weight, Body) 01/2020 - 08/2018
3	Esophageal Squamous Cell Carcinoma 03/2016 - 02/2012
3	Pathologic Constriction (Stenosis) 01/2016 - 06/2004
3	Major Depressive Disorder (Major Depressive Disorders) 01/2014 - 01/2013
2	Cerebral Infarction 06/2022 - 10/2008
2	Atherosclerotic Plaque (Atheroma) 06/2022 - 05/2014
2	Atrophy 01/2022 - 01/2018
2	Dyslipidemias (Dyslipidemia) 08/2021 - 01/2016
2	Cardiovascular Diseases (Cardiovascular Disease) 08/2021 - 01/2019
2	Cerebrovascular Disorders (Cerebrovascular Occlusion) 08/2021 - 04/2011
2	Myocardial Infarction 05/2021 - 01/2021
2	Hemorrhage 05/2021 - 01/2021
2	Thromboembolism 01/2021 - 07/2013
2	Thrombosis (Thrombus) 01/2020 - 10/2009
2	Osteoporotic Fractures 11/2019 - 01/2016
2	Sleep Initiation and Maintenance Disorders (Insomnia) 02/2019 - 03/2018
2	Rheumatoid Arthritis 02/2019 - 03/2018
2	Fibrosis (Cirrhosis) 01/2018 - 06/2011
2	IGA Glomerulonephritis (IGA Nephropathy) 01/2018 - 04/2015
2	Ischemia 02/2017 - 01/2008
2	Parkinson Disease (Parkinson's Disease) 01/2017 - 12/2016
2	Neoplasm Metastasis (Metastasis) 03/2016 - 12/2005
2	Lymphatic Metastasis 01/2016 - 04/2008
2	Infections 11/2014 - 08/2005
2	Hematoma 07/2014 - 12/2012
2	Cerebral Hemorrhage 06/2014 - 12/2012
2	Atherosclerosis 05/2014 - 04/2011
2	Knee Osteoarthritis 11/2013 - 09/2012
2	Chronic Renal Insufficiency 03/2012 - 05/2011

Drug/Important Bio-Agent (IBA)

9	Tissue Plasminogen Activator (Alteplase)FDA Link 01/2022 - 05/2009
8	Biomarkers (Surrogate Marker)IBA 06/2022 - 04/2008
7	Proteins (Proteins, Gene)FDA Link 09/2021 - 04/2008
5	qisheIBA 01/2022 - 01/2010
5	Therapeutic UsesIBA 10/2021 - 02/2009
5	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 10/2019 - 10/2008
4	Warfarin (Coumadin)FDA LinkGeneric 01/2021 - 08/2010
4	musconeIBA 01/2020 - 06/2010
4	Plant ExtractsIBA 07/2014 - 01/2010
4	Huang QiIBA 10/2013 - 01/2010
3	C-Reactive ProteinIBA 06/2022 - 03/2012
3	AntioxidantsIBA 01/2022 - 03/2020
3	Clopidogrel (Plavix)FDA Link 01/2021 - 01/2016
3	AnticoagulantsIBA 01/2021 - 07/2013
3	CytokinesIBA 01/2020 - 06/2010
3	CateninsIBA 07/2019 - 11/2013
3	Glucose (Dextrose)FDA LinkGeneric 06/2015 - 03/2012
3	Heparin (Liquaemin)FDA LinkGeneric 05/2013 - 12/2005
2	Vitamin D FDA LinkGeneric 01/2022 - 11/2019
2	Calcitriol Receptors (Calcitriol Receptor)IBA 01/2022 - 01/2017
2	CreatinineIBA 01/2022 - 05/2021
2	danaparoid (Orgaran)FDA Link 01/2022 - 06/2012
2	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 09/2021 - 03/2016
2	oxidized low density lipoproteinIBA 08/2021 - 01/2016
2	LDL CholesterolIBA 08/2021 - 01/2016
2	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 05/2021 - 09/2019
2	AlbuminsIBA 01/2021 - 05/2012
2	Vitamin K FDA Link 01/2021 - 07/2013
2	CalciumIBA 01/2021 - 01/2019
2	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2021 - 01/2016
2	Fibrinolytic Agents (Antithrombotic Agents)IBA 01/2020 - 08/2015
2	Sucrose (Saccharose)IBA 01/2020 - 01/2019
2	Blood Glucose (Blood Sugar)IBA 09/2019 - 06/2015
2	Methotrexate (Mexate)FDA LinkGeneric 02/2019 - 03/2018
2	LipidsIBA 08/2018 - 01/2016
2	benazepril (Briem)FDA LinkGeneric 08/2018 - 03/2012
2	Long Noncoding RNAIBA 01/2017 - 01/2016
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2017 - 02/2009
2	Transcription Factors (Transcription Factor)IBA 01/2017 - 03/2004
2	MicroRNAs (MicroRNA)IBA 03/2016 - 12/2012
2	Cadherins (E-Cadherin)IBA 01/2016 - 04/2008
2	GalaninIBA 01/2014 - 01/2013
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 05/2013 - 08/2011
2	HomocysteineIBA 03/2012 - 12/2008

Therapy/Procedure

24	Therapeutics 06/2022 - 06/2004
7	Chinese Traditional Medicine (Traditional Chinese Medicine) 05/2021 - 03/2005
6	Secondary Prevention 06/2022 - 10/2008
3	Thrombolytic Therapy 10/2019 - 05/2009
2	Stroke Rehabilitation 05/2021 - 09/2011
2	Length of Stay 04/2021 - 05/2012